Glimepiride 4 mg (Generic)

Product Overview

Glimepiride 4 mg is a prescription oral medication classified as a sulfonylurea, used to improve blood‑glucose control in adults with type 2 diabetes. It is produced by Sun Pharmaceutical Industries Ltd, a globally recognized manufacturer with a strong portfolio in diabetes therapeutics. The product is supplied in strips of 10 tablets and is available in pack sizes of 30, 60, or 90 tablets, allowing patients to select the quantity that best fits their treatment plan.

What is Glimepiride 4 mg

Glimepiride 4 mg represents a higher‑strength dose of this sulfonylurea agent. The tablet is film‑coated and marked with a unique imprint for identification. It is intended for oral use once daily, preferably with the first main meal of the day, and is often prescribed when lower doses fail to achieve target glucose levels.

Uses and Benefits

The primary use of Glimepiride 4 mg is to lower fasting and post‑prandial blood‑glucose concentrations in patients with type 2 diabetes. By stimulating pancreatic beta cells to release insulin, it helps reduce HbA1c by roughly 0.5–1.0% when combined with diet and exercise. The once‑daily dosing schedule supports adherence, and the medication is associated with a lower risk of weight gain compared with some alternative oral agents.

How It Works

Glimepiride binds to the sulfonylurea receptor (SUR1) on pancreatic beta cells, leading to closure of ATP‑sensitive potassium channels. This triggers calcium influx, which prompts insulin secretion. The resulting increase in circulating insulin enhances peripheral glucose uptake and suppresses hepatic glucose production. The drug’s onset of action occurs within 1–2 hours, and its effect lasts up to 24 hours, making once‑daily dosing appropriate.

Dosage Guidelines

Therapy is usually initiated at 1–2 mg once daily, with gradual titration based on glycemic response and tolerability. The maximum recommended daily dose is 8 mg, which may be divided into two doses if clinically indicated. Patients should take the tablet with food to reduce gastrointestinal upset, and regular blood‑glucose monitoring is essential during dose adjustments. Any changes to the dosing regimen should be supervised by a qualified healthcare professional.

Side Effects

Common adverse reactions include hypoglycemia, dizziness, headache, and mild gastrointestinal discomfort such as nausea. Less frequent but serious events can involve skin rashes or elevated liver enzymes. Patients should seek immediate medical attention if they experience signs of severe hypoglycemia, such as confusion, sweating, or loss of consciousness. For a complete list of side effects, consult the FDA prescribing information or reputable drug databases like Drugs.com (Glimepiride Side Effects).

Warnings and Precautions

Glimepiride is contraindicated in type 1 diabetes and in patients with diabetic ketoacidosis. Caution is advised in individuals with renal or hepatic impairment, adrenal insufficiency, or those taking medications that may potentiate hypoglycemia, such as certain antibiotics or antifungals. Pregnant or breastfeeding women should only use the medication if the expected benefit justifies the potential risk, and they must discuss it with their physician. Detailed safety information is available from the National Institutes of Health (NIH) diabetes resource (NIH Diabetes Medication Overview).

Frequently Asked Questions

Question: Can Glimepiride 4 mg be taken together with other diabetes drugs?
Answer: It may be used in combination therapy, but dosing must be individualized and blood‑glucose levels should be monitored closely to avoid excessive hypoglycemia.

Question: How quickly does Glimepiride lower blood sugar?
Answer: Most patients observe a reduction in fasting glucose within 1–2 weeks, with measurable changes in HbA1c typically appearing after 4–6 weeks of consistent use.

Question: Is weight gain common with Glimepiride?
Answer: Modest weight gain can occur as glucose control improves, but it is generally less pronounced than with some other oral agents and can be managed through diet and physical activity.

Question: What should I do if I miss a dose?
Answer: Take the missed dose as soon as you remember, unless it is almost time for the next scheduled dose; do not double up to compensate.

Question: Are there any dietary restrictions while using Glimepiride?
Answer: No specific foods must be avoided, but maintaining a consistent carbohydrate intake and following a balanced diet helps stabilize blood‑glucose levels.

Related Products

• Famotidine 20mg (Generic)
• Omesec 20 mg (Omeprazole)
• Pantocid DSR (Pantoprazole/Domperidone)
• Famotidine 40mg (Generic)
• Famocid 20mg (Famotidine)
• Famocid 40mg (Famotidine)
• Famocid (Famotidine)
• Supatret 0.04% Gel (Tretinoin)
• Supatret 0.1% Gel (Tretinoin)
• Supatret C Gel (Clindamycin/Tretinoin)
• Supatret Gel (Tretinoin)
• Acitretin 25mg (Generic)